Lemonade (NYSE:LMND – Get Free Report) will release its earnings data after the market closes on Tuesday, April 30th. Analysts expect Lemonade to post earnings of ($0.82) per share for the quarter. Lemonade has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties interested in listening to the company’s conference call can do so using this link.
Lemonade (NYSE:LMND – Get Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported ($0.61) earnings per share for the quarter, beating the consensus estimate of ($0.79) by $0.18. The company had revenue of $115.50 million for the quarter, compared to analyst estimates of $111.71 million. Lemonade had a negative return on equity of 31.29% and a negative net margin of 55.12%. The company’s revenue was up 30.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.93) EPS. On average, analysts expect Lemonade to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Lemonade Price Performance
NYSE LMND opened at $17.95 on Friday. The firm has a market cap of $1.27 billion, a PE ratio of -5.26 and a beta of 1.89. The stock’s 50 day simple moving average is $16.85 and its 200 day simple moving average is $16.27. Lemonade has a one year low of $10.27 and a one year high of $24.81.
Insider Transactions at Lemonade
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on LMND shares. Keefe, Bruyette & Woods increased their price target on Lemonade from $16.00 to $18.00 and gave the company a “market perform” rating in a research note on Monday, March 4th. JMP Securities reissued a “market outperform” rating and issued a $40.00 price target on shares of Lemonade in a research note on Monday, April 15th. Piper Sandler restated a “neutral” rating and issued a $17.00 price objective on shares of Lemonade in a report on Thursday, February 29th. Morgan Stanley raised their price objective on Lemonade from $13.00 to $14.00 and gave the company an “underweight” rating in a report on Wednesday, February 28th. Finally, TD Cowen began coverage on Lemonade in a research report on Wednesday, January 10th. They set a “market perform” rating and a $17.00 price target on the stock. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Lemonade currently has a consensus rating of “Hold” and an average target price of $17.11.
Check Out Our Latest Report on LMND
About Lemonade
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Stories
- Five stocks we like better than Lemonade
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- MarketBeat Week in Review – 4/22 – 4/26
- Using the MarketBeat Dividend Tax Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- The How and Why of Investing in Biotech Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.